Andrew Lotery1, Carrie MacEwen2. Show Affiliations » 1. Clinical and Experimental Sciences, Faculty of Medicine, University Hospital Southampton, Southampton SO16 6YD, UK A.J.Lotery@soton.ac.uk. 2. Royal College of Ophthalmologists, London NW1 4QW, UK.
Abstract
Entities: Chemical Disease
Mesh： See more » Angiogenesis Inhibitors/economicsAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/economicsAntibodies, Monoclonal, Humanized/therapeutic useBevacizumabDrug Approval/economicsHumansMacular Degeneration/drug therapyMacular Degeneration/economicsRanibizumabRetinal Diseases/drug therapyState Medicine/economicsUnited Kingdom
Substances： See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabRanibizumab
Year: 2014 PMID： 25406142 DOI： 10.1136/bmj.g6887
Source DB: PubMed Journal: BMJ ISSN： 0959-8138